AzTrials
AzTrials

TrainingNCT06268028

Discharge Training Given to Primiparous Mothers Who Had a Cesarean Delivery

A study testing Training in people with Training, run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to determine the effect of discharge training given to primiparous mothers who gave birth by cesarean section on the level of readiness for discharge. The research is a pre-test-post-test, randomized controlled experimental study. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Training
What is being tested?
Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Jan 2024to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Able to speak and understand Turkish,
  • At least primary school graduate,
  • 18 years and over,
  • Those who gave birth by cesarean section,
  • Primiparous mothers will be included in the research.

Who cannot join

  • Those who have a physical disability (vision, hearing, etc.) that prevents them from taking care of themselves,
  • In a risky postpartum period,
  • Having a history of chronic disease,
  • Those who were hospitalized during pregnancy,
  • Those who do not have their baby with them after birth,
  • Foreign nationals,
  • Mothers with psychiatric diagnoses will not be included in the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Aydın Maternity and Child Health Hospital

    Aydin, 09010

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect on the Level of Readiness for Discharge of Discharge Training Given to Primiparous Mothers Having a Cesarean Delivery : A Randomized Controlled Study

This study aimed to determine the effect of discharge training given to primiparous mothers who gave birth by cesarean section on the level of readiness for discharge.

The research is a pre-test-post-test, randomized controlled experimental study.

Read the detailed description

The research is a pre-test-post-test, randomized controlled experimental study. To prevent selection bias, participants were included in the training and control groups by applying the randomization method. The sample consisted of a total of 70 women (experimental group: 35 women and control group: 35 women). The study was carried out with women who lying to Obstetrics Clinic of Aydın Gynecology and Children's Diseases Hospital and met the study criteria.

Conditions
Training
Being tested
Training
Keywords
Training of discharge, Caesarean section, Primiparous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TrainingBehavioural

    Discharge training

Study groups in NCT06268028
Study groupRoleWhat they receive
EXPERIMENT GROUPExperimentalThe individual identification form was first filled out using the face-to-face interview technique. An explanation given regarding filling out the scale and they will be asked to fill it out by self-reporting method under observation. When the mothers in the training group feel good and ready; discharge training gave using the discharge training brochure prepared by the researchers by reviewing the literature. We provided discharge training in the mother's own room and in an average of 30-45 minutes with a one-on-one training method. Mothers asked to fill out the "RHD-NMF" themselves again, close to postnatal discharge.
Receives: Behavioral: Training
CONTROL GROUPNo interventionStarting from the first (smallest number) room in the clinic, the individual identification form was filled out initially by face-to-face interview technique for mothers who meet the appropriate conditions and agree to participate in the study, according to the randomization order. An explanation given regarding filling out the scale and they will be asked to fill it out by self-reporting method under observation. Mothers asked to fill out the "RHD-NMF" themselves again, close to postnatal discharge.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. A pre-test applied to 70 women who constitute the sample of the research.

    In the pre-test; The individual introduction form and scale used, and the same scale used for the post-test. Individual Introduction Form: Sociodemographic (Age, educational status, health insurance, etc.) and obstetric characteristics (number of pregnancies, number of miscarriages/abortions etc). (15 questions) (RHD-NMF): Scale that evaluates readiness for hospital discharge according to the mother's perception; It consists of four subscales and a total of 23 items. The lowest score that can be obtained from the scale is '0' and the highest score is '220'.

    Measured: 16 weeks

Secondary outcomes (1)
  1. Apost-test applied to 70 women who constitute the sample of the research.

    When the mothers in the training group feel good and ready; discharge training was provided using the discharge training brochure prepared by the researchers by reviewing the literature. Discharge training gave one-on-one in the mother's own room, lasting approximately 30-45 minutes. Lectures and question-answer methods used as training techniques. Close to postpartum discharge, mothers in both groups asked to fill out the "RHD-NMF" (post-test) themselves again.

    Measured: 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2024
  2. Study start10 Jan 2024
  3. Primary completion30 Apr 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06268028
Sponsor's protocol ID
BELMA TA
Status last verified
Aug 2024
First submitted
13 Feb 2024
Last updated
6 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: OUR STUDY WAS SUPPORTED BY TUBITAK-2209-A UNIVERSITY STUDENTS RESEARCH PROJECTS SUPPORT PROGRAM. OUR DATA COLLECTION PROCESS FİNİSHED.

Questions about this trial

What is this clinical trial studying?

A study testing Training in people with Training, run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

A pre-test applied to 70 women who constitute the sample of the research. (time frame: 16 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in